Frankfurt - Delayed Quote EUR
Innate Pharma S.A. (IDD.F)
1.7460
+0.0100
+(0.58%)
At close: April 25 at 8:04:30 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-32,558
-32,558
-19,155
-58,457
-51,767
Investing Cash Flow
20,631
20,631
1,877
-917
-13,370
Financing Cash Flow
-1,966
-1,966
-1,828
26,819
-1,177
End Cash Position
70,605
70,605
84,225
103,756
136,792
Capital Expenditure
-2,351
-2,351
-1,122
-1,330
-11,282
Issuance of Debt
--
--
--
28,700
1,360
Repayment of Debt
-2,361
-2,361
-2,026
-2,069
-2,245
Free Cash Flow
-34,909
-34,909
-20,277
-59,787
-63,049
12/31/2020 - 11/10/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HYL.BR Hyloris Pharmaceuticals SA
6.30
-0.74%
ADAG Adagene Inc.
1.4200
+4.41%
ONWD.BR Onward Medical N.V.
4.0150
-0.12%
ITOS iTeos Therapeutics, Inc.
7.35
-1.47%
NUVL Nuvalent, Inc.
73.48
-0.68%
KYMR Kymera Therapeutics, Inc.
33.26
-0.89%
RLAY Relay Therapeutics, Inc.
3.2000
+0.31%
SGMO Sangamo Therapeutics, Inc.
0.7870
-3.42%
SWTX SpringWorks Therapeutics, Inc.
44.72
-0.47%
BHVN Biohaven Ltd.
19.84
-15.21%